CClinicalTrials.gg
WithdrawnNCT03288935Updated Oct 15, 2024

Trauma Informed Care for Newly Resettled Refugees

An interventional study of TICM and TICO in Mental Stress and Emotional Stress, sponsored by Virginia Commonwealth University. Withdrawn at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-10-15.

Sponsored by Virginia Commonwealth University · Not applicable, Interventional, and Other

Why this study was withdrawn
A substantial decrease in refugee arrivals in Virginia didn't allow the investigator to continue the study as planned.
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The main purpose of this study is to evaluate early-phase interventions for refugee wellness promotion and build evidence for dissemination of the intervention model and curricula through refugee resettlement programs, local and national.

Read the detailed description

This study will examine the main effects of trauma-informed case management (TICM) and trauma-informed cultural orientation (TICO) interventions, respectively, in reducing resettlement distress and increasing coping capacity, which will improve emotional wellness and social adaptation and thus resettlement outcomes. This project will also test the interaction effects of two-tiered intervention model, discerning effective and ineffective components of the intervention model. Differences in effects across intervention conditions may inform how improvement in what outcomes or which phase can affect refugees' wellness and adjustment over time.

02

Conditions studied

  • Mental Stress
  • Emotional Stress

Browse trials for

Keywords

  • refugee
  • trauma-informed case management (TICM)
  • trauma-informed cultural orientation (TICO)
  • PTSD
  • depression
  • refugee resettlement
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Refugee adults who arrive in Richmond or Charlottesville between January and February 2018

Exclusion criteria

Exclusion Criteria:

-

04

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Active comparator
    Group 1 (TICM only)

    Assigned to TICM group after reception \& placement.

    Behavioral: TICM

  • Active comparator
    Group 2 (TICO only)

    Assigned to TICO group after reception \& placement.

    Behavioral: TICO

  • Active comparator
    Group 3 (TICM & TICO)

    Assigned to both TICM and TICO group after reception \& placement.

    Behavioral: TICM · Behavioral: TICO

  • No intervention
    Group 4 (None)

    No additional intervention after reception \& placement

Interventions

  • BehavioralTICM

    The TICM will be designed to include the seven domains of trauma-informed care articulated by SAMHSA (2014): 1) early screening and comprehensive assessment; 2) consumer driven care and services; 3) trauma-informed, responsive and educated workforce; 4) emerging and evidence-informed best practices; 5) safe and secure environments; 6) trauma-informed community partnerships; and 7) a performance monitoring system. The trained agency case managers and staff will provide the TICM to 50 newly resettled refugees during their regular R\&P service period (i.e., 60 days).

  • BehavioralTICO

    The community-based TICO will be based on the Im's CHW that comprises 8 sessions (2 hour per session), co-facilitated by trained refugee peer mentors and community service providers. The TICO sessions will include interactive sessions on healthy eating, healthy body and healthy mind, acculturation \& resettlement stress, understanding trauma and stress, healthy coping, helping others, and community building.

05

What researchers measure

Primary outcomes

  1. Change in resettlement distress

    Penn State Worry Questionnaire, which captures pervasiveness, excessiveness, and uncontrollability of worry. Scores range from 16 to 80 with higher values indicating more worry.

    Time frame: Baseline to 6 months

Secondary outcomes

  1. Change in emotional well-being

    Refugee Health Screener-15, a 75 item screening tool with lower scores indicating better well-being

    Time frame: Baseline to 6 months

  2. Resettlement Outcomes

    Post-Migration Living Difficulties, a self-assessment tool which measures adverse post -migration experiences in five different domains, included two related asylum-seeking factors. Scores range from 23 to 115 with higher values indicating more serious problems.

    Time frame: Baseline to 6 months

  3. Change in Social Adaptation

    Social Adaptation Self-evaluation Scale. Scores range from 0 to 63 with higher values indicating better social adjustment.

    Time frame: Baseline to 6 months

06

Study locations

1 site
  • Virginia Commonwealth University
    Richmond, Virginia 23298, United States
07

Registry details

Key details

Study ID
NCT03288935
Lead sponsor
Virginia Commonwealth University
Responsible party
Sponsor
First posted
Sep 20, 2017
Start date
Aug 28, 2018
Primary completion
Mar 20, 2019
Completion
May 15, 2019
Last update
Oct 15, 2024

Study contacts

Hyojin Im, PhD
principal investigator · Virginia Commonwealth Univeristy

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion